Artemend is poised to be the next evolution in early stage breast cancer treatment. A major medical center is interested in adding Artemend to help treat breast cancer in 5 states. We completed six years of clinical trials with a 92% nonrecurrence rate and a 98% patient satisfaction rate. Benefits include a single procedure, fast recovery, minimal side effects and lower cost. Over 210,000 women could benefit from this new treatment per year..